We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 10,000 results
  1. A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance

    Purpose

    HER3, a member of the EGFR receptor family, plays a central role in driving oncogenic cell proliferation in breast cancer. Novel HER3...

    Nicoleta Sinevici, Christine E. Edmonds, ... Umar Mahmood in Breast Cancer Research
    Article Open access 29 June 2024
  2. Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer

    Neoadjuvant cisplatin-based chemotherapy is recommended prior to surgical removal of the bladder for patients with non-metastatic muscle invasive...
    Jussi Nikkola, Peter Black in Urothelial Carcinoma
    Protocol 2023
  3. Shifting the paradigm: engaging multicellular networks for cancer therapy

    Most anti-cancer modalities are designed to directly kill cancer cells deploying mechanisms of action (MOAs) centered on the presence of a precise...

    Joyce Hu, Paolo Ascierto, ... Francesco M. Marincola in Journal of Translational Medicine
    Article Open access 12 March 2024
  4. A Brief Introduction to Current Cancer Gene Therapy

    Gene therapy has started in the late 1980s as novel, clinically applicable therapeutic option. It revolutionized the treatment of genetic diseases...
    Dennis Kobelt, Jessica Pahle, Wolfgang Walther in Gene Therapy of Cancer
    Protocol 2022
  5. Graphene-based hybrid composites for cancer diagnostic and therapy

    The application of graphene-based nanocomposites for therapeutic and diagnostic reasons has advanced considerably in recent years due to advancements...

    Mahnaz Asadi, Seyed Hosein Ghorbani, ... Mohammad Aghamohammadi in Journal of Translational Medicine
    Article Open access 02 July 2024
  6. The Intricacy of ROS in Cancer Therapy Resistance

    Cancer is one of the notable causes of death universally due to the emergence of therapy resistance despite the evolution of encouraging therapeutic...
    Chandan Kanta Das, Ranabir Majumder, ... Mahitosh Mandal in Handbook of Oxidative Stress in Cancer: Mechanistic Aspects
    Reference work entry 2022
  7. Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer

    Liver cancer is a major malignant tumor, which seriously threatens human health and increases the economic burden on patients. At present, gene...

    Junhe Zhang, Yunxi **ao, ... Fan Liang in Journal of Translational Medicine
    Article Open access 02 January 2024
  8. Role of the microbiota in response to and recovery from cancer therapy

    Our understanding of how the microbiota affects the balance between response to and failure of cancer treatment by modulating the tumour...

    Stephen J. Blake, Yochai Wolf, ... David J. Lynn in Nature Reviews Immunology
    Article 06 November 2023
  9. Application of Oncolytic Poxviruses: An Emerging Paradigm in Cancer Therapy

    Despite the significant advancement of new tools and technology in the field of medical biology and molecular biology, the challenges in the...
    Prasenjit Chakraborty, Randhir Kumar, ... Priya Mondal in Poxviruses
    Chapter 2024
  10. Injectable hydrogel systems for local cancer therapy

    Background

    Injectable hydrogels have attracted significant attention for localized cancer treatment due to their tuned viscoelasticity, self-healing...

    Sungyun Kim, Dae-Duk Kim, ... Hyun-Jong Cho in Journal of Pharmaceutical Investigation
    Article 14 June 2024
  11. Targeting the Metabolism in Cancer Cells for Cancer Therapy

    Cellular reactive oxygen species (ROS) are a group of extremely reactive molecules and are produced by metabolic and other reduction-oxidation...
    Manju Mohan, Shabana Thabassum Mohammed Rafi, ... R. Ileng Kumaran in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  12. Cancer Stem Cell Oxidative Phosphorylation: Target for Cancer Therapy

    Cancer is one of the most important leading causes of death across the globe. Cancer cells that divide uncontrollably are killed by chemotherapy,...
    Arvind Palani, Rifika Jain, Gnanasekar Munirathinam in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  13. Nanotechnology in ROS-induced Cancer Therapy

    Utilization of nanotechnology in the cancer therapy has produced nano-based products that can produce reactive oxygen species (ROS) cytotoxicity with...
    Reference work entry 2022
  14. Nanotechnology in ROS-induced Cancer Therapy

    Utilization of nanotechnology in the cancer therapy has produced nano-based products that can produce reactive oxygen species (ROS) cytotoxicity with...
    Living reference work entry 2022
  15. Targeting the Metabolism in Cancer Cells for Cancer Therapy

    Cellular reactive oxygen species (ROS) are a group of extremely reactive molecules and are produced by metabolic and other reduction-oxidation...
    Manju Mohan, Shabana Thabassum Mohammed Rafi, ... R. Ileng Kumaran in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  16. Cancer Stem Cell Oxidative Phosphorylation: Target for Cancer Therapy

    Cancer is one of the most important leading causes of death across the globe. Cancer cells that divide uncontrollably are killed by chemotherapy,...
    Arvind Palani, Rifika Jain, Gnanasekar Munirathinam in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  17. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer

    Cancer stem cells (CSCs), initially identified in leukemia in 1994, constitute a distinct subset of tumor cells characterized by surface markers such...

    Zhen Zeng, Minyang Fu, ... Min Luo in Molecular Cancer
    Article Open access 18 October 2023
  18. Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis

    Background

    Adoptive cell transfer cancer immunotherapy holds promise for treating disseminated disease, yet generating sufficient numbers of...

    Odd L. Gammelgaard, Mikkel G. Terp, ... Henrik J. Ditzel in Molecular Cancer
    Article Open access 06 January 2024
  19. Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review

    Introduction

    Focal therapy (FT) is a promising alternative to whole-gland treatments for Localized Prostate Cancer. Ten different FT modalities have...

    Rossella Nicoletti, Andrea Alberti, ... Jeremy Yuen Chun Teoh in Prostate Cancer and Prostatic Diseases
    Article 28 July 2023
  20. Radiopharmaceuticals: A New Era in Cancer Therapy – Light on Initial Findings on Animal Model

    In recent years, the worldwide cancer burden has increased dramatically. The treatment modalities for cancer are surgery, radiation therapy, and...
    Ahamed Basha Abdul Bari, Prince Johnson Samuel, Siva Shankar Rangasamy in Handbook of Animal Models and its Uses in Cancer Research
    Reference work entry 2023
Did you find what you were looking for? Share feedback.